Thrombocytopenia in liver disease · 3 regimens
Cost vs Efficacy
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
Avatrombopag monotherapy Variant #01 Partial | — | — | 5d | — | — | — | — | — |
Placebo Partial | — | — | — | ~4.2 mo | ~8.0 mo | — | — | 145 |
Lusutrombopag monotherapy Variant #01 Partial | — | — | 7d | — | — | — | — | — |
3 of 3 regimens shown